VIATRIS (Mylan Laboratories Limited), is a new kind of healthcare Company, committed to providing access to medicines, advancing sustainable operations developing innovative solutions, and leveraging our collective expertise to improve patient outcomes.
We Are Hiring. Viatris is more than just a place to work. It’s a place where you can learn, grow and make an impact in the world. Mylan Laboratories Limited (A Viatris Company) is hiring for it’s OSD Manufacturing Facility at Pithampur, Indore.
Departments:
- Quality Assurance
- Quality Control
- Engineering
- Experience: 2-6 yrs
- Qualification: M.Sc / B.Pharm / M.Pharm / B.Tech / Diploma
Registration:
- Click here to apply :-> https://forms.gle/BHaH8GadtJkTfhKt8
Or
Use the QR code below
Job Description:
Quality Assurance:
- Documentation(QMS):- Should have good communication skill, sound knowledge of Deviations, APQR, Market Complaints, Change Control, CAPA, Cleaning Validation, Self-Inspection, Process Validation, Risk Assessment, BMR preparation, SOP preparation, Vendor Management & QA documentation etc.
- Lab QA: Analytical Quality Assurance- Should have experience of Analytical data review. Should have sound knowledge of OOS, OOT, Change Control, Deviations etc.
Quality Control:
- Candidates having hands-on experience in Analysis of Raw Material, Packaging Material, Finished Goods, Stability, Method Transfer and Laboratory Investigations.
- Hands-on experience in HPLC, GC, Dissolution and other instrumental analysis.
Computer Proficiency: QMS / SAP / LIMS / Trackwise.
Engineering :
- Candidates having hands on experience on HVAC, Purified Water System along with knowledge of Qualification, Calibration, Process equipment maintenance & Documentation knowledge.
- Knowledge about PLC’s, SCADA System & Instruments


Walk-In Interview Details:
- Date: 2nd Feb’ 2025
- Time: 10:00 Hrs. to 15:00 Hrs.
- Venue: Goa (Venue details will be shared with shortlisted candidates)
- Kindly Share CV’s on hr.indore@viatris.com & Scan the QR Code to Apply.
- Last Date: 31 January 2025.